Victoria Kronsten
@vtkronsten
Followers
298
Following
652
Media
1
Statuses
127
Academic Clinical Fellow in Hepatology, KCH, PhD student at KCL. BASL Trainee Subcommittee South East Rep, BASL SoMe Working Group member.
London, England
Joined November 2020
To trainees attending the upcoming #BASL2025 meeting, trainees’ committee has organised a meet & greet session! Great opportunity to network, foster new collaborations & speak with regional trainee reps! Meeting room 3, Friday, 10:45am! https://t.co/RrwPibRcKN
@BASLedu
0
6
6
🔥 New insights on Autoimmune Hepatitis (AIH) treatment! 🔬 From personalized thiopurine therapy 💊 to mycophenolate mofetil (MMF) as a 1st-line option, and advanced biologics like infliximab & rituximab 🌟—discover strategies to tackle difficult-to-treat AIH and improve patient
0
31
87
Last week, clinical teams from across the UK recruiting to the PROMISE trial came together at King's to share insights and learnings. They were joined by patient representatives who shared their stories and experiences of being part of the trial. Speaking of the day, Chief
0
3
14
Following the @EASLnews annual congress earlier this month in Amsterdam, we’re celebrating our very own Prof. @DebbieShawcros1 and her new role as Secretary General of EASL, a key post within the international landscape of liver research 👏👏 Full article:
1
7
27
Today is World Clinical Trials Day! Thank you everyone for your ongoing support on PROMISE🥳👏 - see our new blog on the @LiverTrust website: The PROMISE trial – get involved in research looking at a very different type of medicine. #ClinicalTrial #NIHRresearch @DebbieShawcros1
1
3
7
Don’t miss the Rare Liver Disease Masterclass! 15–16 June 2025 | London Hear from international experts on Wilson’s Disease, cholestatic liver disorders, alpha-1 antitrypsin deficiency, clinical trials & more. 🔗 Full programme : https://t.co/aL9oRZwKTB – register now!
0
8
7
Great to see #JadeKing any my editorial in @LTxJournal
https://t.co/3Q1wDx9vUc discussing the psychological and cognitive impact of liver disease and transplantation on patients as well as the potential role of prehabilitation in addressing this @liverphysio
1
7
11
This was my absolute highlight of #ECCO2025 So glad I stayed late to hear the big reveal. Low emulsifier diets will change clinical and patient’s lives. Massive congratulations @ProfWhelan & @AaronBancil
Excited to announce results of our #ADDapt trial After 6 years and the help of 154 people with #CrohnsDisease we prove that restricting #emulsifiers improves disease Award winning presentation from @AaronBancil at #ECCO25 Excited for next steps to help people with Crohns
2
10
44
📢Adolescent sobriety under siege ➡️An urgent call to protect children from alcohol harms ➡️EASL calls on all countries to establish and enact comprehensive strategies to mitigate alcohol-related harms 🔗 https://t.co/iiVWaBcN5L
#LiverTwitter
@EASLnews
@EASLedu
@EASLEUAffairs
0
11
13
Very proud to have this published! Thank you to the Lancet and it’s incredible editorial team for your collaboration on this project. Some important updates, hope you find it useful! Appendix has lots of information about pregnancy in AIH, PBC, PSC and Wilson’s too.
Physiological changes that occur in pregnancy can exacerbate or improve some pre-existent liver diseases. A new Review describes the challenges of diagnosing, risk stratifying, and managing liver disease in pregnancy: https://t.co/RG4k6LY0ZK
4
14
35
❌💊 Simvastatin + rifaximin does not prevent ACLF development in decompensated cirrhosis ⏳10 years of work in the books 💪🏼 @salvatore_piano @Zac_MD @KGananandan @UschnerFrank @JonelTrebicka @ruben_hernaez @JuanAbraldes @JordiGratacos8 @dewitkoos @EASLnews @AASLDtweets
In this clinical trial, addition of simvastatin plus rifaximin to standard therapy did not improve outcomes in patients with decompensated liver cirrhosis. https://t.co/ewO0H4cpw9
7
40
91
@STGHepatology PhD/MD opportunity, clinical research fellow post (ST4+) to start in September 2025. Post-CCT individuals welcome. Come and join our wonderful, friendly, diverse and fun (!) team. Link below, please share with anyone who might be interested. Don’t be shy, come have a chat!
0
9
11
Happy to announce that we have achieved 💯out of 300 randomisations in the PROMISE trial. Thank you everyone for your amazing work, let's keep going in 2025! #FMT #clinicaltrials #livercirrhosis @DebbieShawcros1 @vtkronsten
5
4
15
A great start to 2025! 1st participant randomised by the Nottingham team! @NHSNotts 9⃣9⃣ recruited, 1 more to 💯! Happy New Year everyone! #fmt #clinicaltrials #liver #cirrhosis @DebbieShawcros1 @vtkronsten
0
2
6
Delighted to share @vtkronsten recent review in @AmJGastro Clinical Implications of Inflammation in Patients With Cirrhosis https://t.co/DhvXIGAKSO
@JasmohanBajaj @kingsmedicine @KingsCollegeNHS @Inst_of_Liver
journals.lww.com
state with coexistent severe immune paralysis that defines acute decompensation and acute-on-chronic liver failure. Systemic inflammation plays a crucial role in the disease course of cirrhosis and...
0
6
20
How to differentiate depression & anxiety from encephalopathy? How can we safely treat them when the patient doesn't want to go to a mental health specialist? This review on depression & anxiety in cirrhosis is very useful. https://t.co/wu4t4vFdpZ
1
13
52
After highlighting the steep rise in alcohol-related liver disease in young women, we now highlight an even bigger problem in our children. The highest prevalence of lifetime alcohol use for 11-year-olds (34% girls) was observed in the UK. @Inst_of_Liver
https://t.co/3FQHywrfka
2
26
33
📣 Please do watch @BBCPanorama tomorrow at 8pm. “Binge Drinking and Me.” The programme will focus on the rapidly rising rate of alcohol-related liver disease in UK young women. We will also be discussing this @BBCRadio4 Women’s Hour & @bbc5live with Naga Manchetty. @LiverTrust
7
27
65